Citric Acid

Citric acid is a naturally occurring weak organic acid found abundantly in citrus fruits and is one of the most widely used food additives in the world. It serves primarily as an acidity regulator, preservative, and flavor enhancer, imparting a clean, sharp tartness to foods and beverages. Its safety profile is well established across major global regulatory bodies, which grant it GRAS (Generally Recognized as Safe) or equivalent status.

Although citric acid occurs naturally in lemons, limes, and other fruits, the vast majority used commercially is produced through the fermentation of glucose or sucrose by the mold Aspergillus niger. This biotechnological manufacturing route has been the industry standard since the early twentieth century and allows production at the scale required by the global food, beverage, pharmaceutical, and cleaning industries.

In food systems, citric acid performs multiple technical functions simultaneously: it lowers pH to inhibit microbial growth, chelates metal ions that would otherwise catalyse rancidity, enhances the perception of fruit flavors, and acts as a buffering agent. These combined properties make it indispensable in soft drinks, jams, canned goods, confectionery, and many processed foods.

From a public health perspective, the main area of documented concern is the acid's erosive potential on dental enamel when consumed frequently and in concentrated form—a well-established finding consistent with its low pH. Systemic toxicity at normal dietary exposure levels is not a recognized concern. Ongoing research continues to examine its effects on gut microbiota and metabolic signaling, though evidence in these areas remains preliminary.

Citric acid is a triprotic weak acid belonging to the hydroxy acid family. Its molecular backbone is a three-carbon propane chain bearing three carboxylic acid groups (–COOH) at positions 1, 2, and 3, and a single hydroxyl group (–OH) at position 2, making it both a tricarboxylic acid and an alpha-hydroxy acid. The three dissociable protons give it pKa values of approximately 3.13, 4.76, and 6.40, allowing it to act as a highly effective buffering agent across a wide pH range relevant to food systems. The hydroxyl group on the central carbon also enables chelation of divalent metal cations such as iron (Fe²⁺) and copper (Cu²⁺), underpinning its antioxidant-synergist function. Citric acid is achiral in its free acid form (the central carbon bears two identical –CH₂COOH arms), and it is a key metabolite in the tricarboxylic acid (Krebs) cycle present in virtually all aerobic organisms.

The overwhelming majority of commercial citric acid—estimated at over 95% of world production—is manufactured through submerged aerobic fermentation. The industrial microorganism of choice is Aspergillus niger, a filamentous fungus capable of accumulating large quantities of citric acid under carefully controlled conditions of high sugar concentration, low pH, low manganese ion content, and sufficient aeration. Glucose or sucrose derived from corn starch, sugar beet molasses, or sugarcane molasses serves as the carbon feedstock. After fermentation (typically lasting 5–14 days), the broth is filtered to remove fungal biomass, and citric acid is precipitated as calcium citrate by adding calcium hydroxide. The calcium citrate is then treated with dilute sulphuric acid to liberate free citric acid and precipitate calcium sulphate (gypsum) as a by-product. The resulting citric acid solution is further purified through activated carbon treatment, ion exchange, and evaporative crystallisation to yield food-grade or pharmaceutical-grade product. An alternative process using Candida yeast strains on n-alkane feedstocks exists but is commercially marginal. Synthetic chemical routes exist but are economically uncompetitive and are not used at commercial scale for food-grade citric acid.

Citric acid was first isolated in 1784 by the Swedish-German chemist Carl Wilhelm Scheele, who crystallised it from lemon juice. For much of the nineteenth century, commercial supply relied entirely on extraction from Italian citrus fruit—particularly lemon juice from Sicily—making it expensive and geographically concentrated. In 1893, Carl Wehmer discovered that Penicillium molds could produce citric acid through fermentation, but the process was commercially unreliable. The critical breakthrough came in 1917 when American food chemist James Currie demonstrated that Aspergillus niger, cultivated under acidic, high-sugar conditions, could produce citric acid with high efficiency. Pfizer Inc. commercialised this fermentation route in 1919, rapidly displacing citrus extraction as the dominant production method. By the mid-twentieth century, industrial fermentation had made citric acid inexpensive and globally available, spurring its adoption across the food, pharmaceutical, and industrial cleaning sectors. Global production now exceeds 2 million metric tonnes per year, with China accounting for the largest share of manufacturing capacity.

• Acidity regulation: Lowers and stabilises the pH of food products, creating an environment hostile to spoilage microorganisms and pathogenic bacteria.
• Flavor enhancement: Imparts a clean, bright tartness that enhances fruit, berry, and citrus flavor profiles without masking other notes.
• Preservation: Inhibits microbial growth by reducing water activity (indirectly via pH) and by chelating metal ions that catalyse oxidative spoilage.
• Antioxidant synergist: Chelates pro-oxidant metal ions (Fe²⁺, Cu²⁺), preventing them from initiating lipid oxidation; potentiates the effectiveness of primary antioxidants such as ascorbic acid and tocopherols.
• Emulsion stabilisation: Helps stabilise fat emulsions by controlling pH and ionic environment.
• Gelling agent activator: Activates low-methoxyl pectin gelation in reduced-sugar jams by modulating pH and calcium availability.
• Color preservation: Prevents enzymatic browning in cut fruits and vegetables by lowering pH and chelating the copper co-factor of polyphenol oxidase.
• Cleaning and buffering in processing: Used as a CIP (clean-in-place) agent and rinse aid in food-manufacturing environments.
• Cost-effectiveness: Highly affordable, readily available globally, and effective at low concentrations.

Citric acid is an endogenous metabolite—it is a central intermediate in the tricarboxylic acid (Krebs) cycle through which all aerobic cells generate energy—so its presence in the human body is entirely normal and essential. At the levels encountered through dietary intake, it does not require the body to undertake any unusual metabolic processing.

Mineral absorption: There is moderate, consistent evidence that citric acid enhances the intestinal absorption of minerals, including calcium, magnesium, and iron, by forming soluble chelate complexes that remain bioavailable at intestinal pH. This property is deliberately exploited in some mineral supplements (e.g., calcium citrate formulations), where citrate salts are better absorbed than carbonate forms, particularly in individuals with low gastric acid secretion.

Kidney stone prevention (clinical context): Potassium citrate and sodium citrate—salts of citric acid—are well-established pharmaceutical treatments for calcium oxalate and uric acid kidney stones. Citrate in urine inhibits crystal aggregation and raises urinary pH. While dietary citric acid from food does contribute to urinary citrate, the clinical benefit has primarily been studied and established for pharmaceutical citrate salts rather than food-additive doses of citric acid itself.

Antimicrobial contribution: By lowering food pH, citric acid contributes to the overall safety of preserved and acidified foods, indirectly benefiting public health by reducing pathogen survival—though this is a food-safety rather than direct physiological benefit.

No specific nutritional or therapeutic benefit is attributed to citric acid as a food additive at normal exposure levels beyond the metabolic role common to all intermediates of central metabolism.

Dental Erosion (Established)

The most consistently documented risk associated with dietary citric acid is erosion of dental enamel. This is an established, well-evidenced finding. Because citric acid lowers the pH of beverages and foods well below the critical level for enamel dissolution (~pH 5.5), frequent or prolonged oral contact—as occurs with sipping acidic soft drinks or sucking sour sweets over extended periods—demineralises enamel. The risk is directly related to frequency, duration of oral contact, concentration, and individual salivary buffering capacity, rather than a specific toxicological property of citric acid itself. Good oral hygiene practice, including waiting before brushing after consuming acidic foods, is recommended.

Gastrointestinal Irritation (Limited Evidence)

Some individuals report gastrointestinal discomfort (heartburn, reflux exacerbation, stomach upset) following consumption of highly acidic foods or beverages containing citric acid. The evidence for this is largely anecdotal and based on small observational studies. People with gastro-oesophageal reflux disease (GORD) or erosive oesophagitis are commonly advised to moderate intake of acidic foods, but citric acid is not uniquely causative—any acidic food could have similar effects.

Mold-Derived Production Concerns (Ongoing Research / Very Limited Evidence)

Because commercial citric acid is produced by Aspergillus niger—a species capable of producing aflatoxins under certain conditions—some researchers and consumer advocates have raised the question of whether trace fungal metabolites or residual proteins might remain in the final product. The scientific consensus is that, under properly controlled Good Manufacturing Practice (GMP) conditions and with appropriate purification steps, no toxicologically relevant quantities of mycotoxins or residual allergens are present in food-grade citric acid. Regulatory authorities have not identified this as a public health concern. A small number of case reports describe apparent hypersensitivity reactions in individuals also sensitive to Aspergillus molds, but causal attribution is difficult and these reports are rare.

Potential Effects on Gut Microbiota (Early/Preliminary Research)

Some in vitro and animal studies have begun examining how sustained acidification of gut contents by organic acids, including citric acid, might influence microbial community composition. This research is in early stages and has not produced consistent findings applicable to normal human dietary exposure. No clinical or epidemiological evidence currently supports concern at typical intake levels.

Systemic Toxicity (Not Established at Dietary Levels)

Citric acid is not classified as a carcinogen, mutagen, reproductive toxin, or endocrine disruptor by any major regulatory authority. High-dose animal studies have consistently failed to demonstrate systemic toxicity at exposures far exceeding normal human dietary intake.

The Joint FAO/WHO Expert Committee on Food Additives (JECFA) evaluated citric acid and its sodium, potassium, and calcium salts and concluded that an Acceptable Daily Intake (ADI) of 'not specified' (or 'not limited') is appropriate. This designation—the most permissive category—indicates that, based on available toxicological data, the total intake of citric acid arising from its use at levels necessary to achieve its intended technological effect poses no health hazard. An explicit numerical ADI was therefore considered unnecessary.

The European Food Safety Authority (EFSA) reaffirmed this position in its re-evaluation of citric acid (E330) and citrate salts (E331–E333) published in 2014, concluding that there was no safety concern for the general population at reported use levels.

Adults: No numerical upper limit is set. Normal dietary exposures from food are well within any margin of safety demonstrated in animal studies.

Children: EFSA noted that exposure estimates for children, who tend to have higher body-weight-adjusted intakes of soft drinks and confectionery, can exceed those of adults on a per-kg basis, but that exposures were still not of toxicological concern. Dental erosion risk in children is, however, a distinct public health consideration given the vulnerability of developing dentition.

Pregnancy and lactation: No specific restrictions apply. Citric acid is a normal product of human intermediary metabolism and is considered safe during pregnancy at dietary intake levels. High-dose supplemental citrate salts in clinical settings should be managed medically.

Individuals with renal impairment: Patients with severe kidney disease who are managing citrate or mineral intake should consult a healthcare provider, as citrate salts can affect acid-base balance; however, citric acid as a food additive is not specifically contraindicated.

Citric acid is among the most thoroughly studied food additives, benefiting from decades of toxicological, biochemical, and clinical research. The foundational safety evaluation was conducted by JECFA, which reviewed acute, subacute, and chronic animal toxicity studies, reproduction and teratology studies, and metabolic data. These studies consistently found very high No-Observed-Adverse-Effect Levels (NOAELs) and confirmed rapid metabolic assimilation via the Krebs cycle.

Dental erosion: A substantial body of peer-reviewed literature—including controlled laboratory studies, clinical trials, and epidemiological surveys—has established a causal link between frequent consumption of citric-acid-containing beverages and dental enamel erosion. Work by Lussi et al. and subsequent systematic reviews (including a 2019 meta-analysis in Journal of Dentistry) confirm that pH, titratable acidity, and chelating capacity are the key erosive variables, with citric acid scoring high on all three.

Mineral bioavailability: Multiple randomised controlled trials and pharmacokinetic studies have demonstrated superior calcium and magnesium absorption from citrate salts compared to carbonate or oxide forms, particularly in hypochlorhydric individuals. A 1990 study by Harvey et al. in Journal of Bone and Mineral Research is frequently cited.

Kidney stone research: Pak et al.'s clinical trials (published in Journal of Urology, various years) established the efficacy of potassium citrate in reducing calcium oxalate stone recurrence. The contribution of dietary citric acid from food sources to urinary citrate excretion has been examined but is considered modest compared to pharmacological citrate supplementation.

Gut microbiome: Emerging in vitro and animal studies (e.g., published in Nutrients, 2020–2023) have begun probing the effects of organic acid-mediated pH changes in the gut on microbiota diversity. Results are inconsistent and not yet sufficient to draw conclusions applicable to human dietary exposure at normal intake levels. This remains an active but preliminary area of research.

Aspergillus niger and residual proteins: A small number of case reports and one methodologically limited study (Sweis & Cressey, 2012, discussed in Clinical and Experimental Allergy) suggested possible reactions in mold-sensitive individuals, but rigorous challenge studies confirming a causal mechanism are absent. Regulatory assessments have not identified this as a population-level concern.

Citric acid has attracted a modest but persistent wave of public concern, amplified primarily through social media and natural-health advocacy platforms. A recurring claim holds that because commercial citric acid is produced by Aspergillus niger—a mold—it is inherently toxic, that it causes systemic inflammation, and that it is responsible for a broad range of symptoms from joint pain to fibromyalgia. These claims are not supported by the toxicological or clinical literature. Citric acid produced via fermentation undergoes extensive purification and is chemically identical to the molecule found naturally in citrus fruits; the manufacturing organism does not confer any special toxicity to the end product.

A related claim is that citric acid is 'not natural' because it is fermented from corn starch (sometimes derived from genetically modified maize), making it unsuitable for people seeking 'clean label' or 'natural' foods. This concern reflects consumer preference rather than a safety issue; regulators in the USA and EU do not classify citric acid produced by fermentation as anything other than citric acid, regardless of the feedstock's origin.

Concerns about dental erosion, in contrast, are scientifically legitimate and have been accurately conveyed in public health messaging by dental associations in the UK, Australia, and the USA. The nuance—that the risk relates to frequency and manner of consumption rather than single exposures—is sometimes lost in media coverage, which tends to frame any acidic beverage as uniformly harmful to teeth.

Citric acid has also been incorrectly conflated with citrus allergies in popular media. A true allergy to citrus fruit involves sensitisation to fruit proteins (particularly lipid transfer proteins), not to citric acid, which is not an allergen. People who report reactions to citrus but tolerate purified citric acid are demonstrating this distinction in practice.

The primary environmental concern associated with industrial citric acid production is the large-scale fermentation process and its associated waste streams. The calcium sulphate (gypsum) generated as a by-product of the traditional calcium precipitation purification method represents a significant solid waste challenge; a typical production facility generates roughly one tonne of gypsum per tonne of citric acid produced. While gypsum is not acutely toxic and has applications in construction and agriculture, managing large volumes sustainably requires careful planning. Some modern facilities have shifted to membrane-based or chromatographic purification to reduce gypsum generation.

Fermentation itself requires substantial quantities of carbohydrate feedstock, water, and energy (for aeration, temperature control, and downstream processing). The carbon footprint of citric acid production is therefore non-trivial. Life cycle assessments published in peer-reviewed journals suggest that Chinese facilities—which dominate global production—have higher energy intensities than comparable European or North American plants, largely due to differences in the electricity grid and process efficiency. Wastewater from fermentation contains residual organic material with high biological oxygen demand (BOD), requiring treatment before discharge.

In contrast, citric acid in the environment is readily biodegradable (it is a normal metabolite of microbial and plant metabolism) and does not bioaccumulate. It is not classified as an environmental hazard under European chemical regulations (CLP Regulation). Its use as a biodegradable substitute for phosphates in cleaning products is sometimes cited as an environmental benefit relative to legacy formulations.

Workers involved in the production and handling of citric acid powder or concentrated solutions may be exposed through inhalation of dust or aerosols and through skin or eye contact. Acute inhalation of citric acid dust can cause irritation of the upper respiratory tract, nose, and throat. The compound is classified as an irritant but not as a carcinogen, mutagen, or respiratory sensitiser by major occupational health authorities including NIOSH and the EU harmonised classification system.

Occupational exposure limits (OELs) for citric acid have been established in some jurisdictions as time-weighted average (TWA) values; for example, the American Conference of Governmental Industrial Hygienists (ACGIH) has proposed a Threshold Limit Value (TLV) of 2 mg/m³ (as an inhalable fraction). Standard personal protective equipment—including dust masks (P2/N95 grade for dusty environments), safety glasses, and gloves—is recommended in production settings.

Skin contact with concentrated solutions or wet powder can cause mild irritation; prolonged contact may exacerbate pre-existing dermatitis. There is no established evidence for sensitisation or occupational asthma attributable to citric acid itself, although any dusty environment carries non-specific respiratory risk. Standard industrial hygiene practices—local exhaust ventilation, enclosed handling systems, and regular monitoring of ambient concentrations—are the primary protective measures.

Extensive acute, subacute, and chronic animal toxicity studies have been conducted on citric acid, primarily in rats and mice, as part of regulatory evaluations by JECFA, the FDA, and EFSA. Acute oral LD₅₀ values are high (approximately 3,000–6,000 mg/kg body weight in rodents), confirming low acute toxicity. Chronic dietary administration studies at doses far exceeding realistic human exposure did not produce evidence of carcinogenicity, organ-specific pathology, or reproductive toxicity. Teratology studies in rats and rabbits similarly found no adverse developmental effects at doses below those causing maternal toxicity.

High-dose administration of citric acid and citrate salts in rodents has been shown to affect calcium and mineral metabolism, consistent with their known chelating properties, but these effects are not observed at exposure levels relevant to dietary intake in humans. Some rodent studies examining urinary tract effects at very high doses have been conducted in the context of kidney stone research, confirming that citrate supplementation reduces calcium oxalate crystallisation—a finding consistent with clinical observations in humans.

As noted under 'Scientific Research', some in vitro and animal models have begun examining citric acid's effects on gut microbial ecology, but these studies use supraphysiological concentrations and are not directly applicable to normal dietary exposure.

Human metabolism studies confirm that orally ingested citric acid is rapidly and completely absorbed from the gastrointestinal tract and enters intermediary metabolism as a Krebs cycle intermediate. It does not accumulate in tissues and is ultimately oxidised to carbon dioxide and water. At normal dietary intake levels, no measurable change in blood citrate concentrations is produced, as the metabolic machinery rapidly processes absorbed citric acid.

Clinical studies have demonstrated enhanced intestinal absorption of calcium, magnesium, and iron when these minerals are co-administered with citric acid or presented as citrate salts, compared to carbonate or other forms. This is particularly relevant for individuals with achlorhydria or those taking proton pump inhibitors, where low gastric acid secretion impairs dissolution of less-soluble mineral salts.

Controlled human studies on dental erosion have confirmed a direct relationship between consumption of citric-acid-containing beverages and enamel loss, with the degree of erosion correlated with pH, titratable acidity, and frequency of consumption. Cross-sectional epidemiological studies in children and adolescents in the UK and Australia have linked high soft drink consumption to increased prevalence of dental erosion, though attributing this specifically to citric acid versus other dietary acids (e.g., phosphoric acid, carbonic acid) is methodologically challenging.

Small-scale human pharmacokinetic studies have examined the urinary excretion of citrate following dietary ingestion of citric acid, finding modest increases in urinary citrate that may confer some protection against calcium oxalate stone formation, though effects are considerably smaller than those achieved with pharmacological potassium citrate supplementation.

In most jurisdictions, citric acid must be declared on ingredient labels when it is intentionally added to a food product. The specific labeling requirements vary by region:

• United States (FDA): Listed by its common or usual name, 'citric acid', in the ingredient list in descending order of predominance by weight.
• European Union and United Kingdom: May be listed as 'citric acid' or by its E number, E330, in the ingredient list. Both formats are legally acceptable and interchangeable.
• Australia and New Zealand (FSANZ): Declared as 'citric acid' or by its additive number, 330, in the ingredient list.
• Canada: Listed as 'citric acid' in the ingredient list in French and English on bilingual labels ('acide citrique' in French).

Alternative names that consumers may encounter on labels include 'E330', 'acidity regulator (330)', 'acidity regulator (citric acid)', or, in buffered applications, references to sodium citrate (E331), potassium citrate (E332), or calcium citrate (E333)—which are salts of citric acid with distinct E numbers. Citric acid does not appear under covert or misleading trade names; its labeling is straightforward by regulatory requirement.

Citric acid is one of the most abundant naturally occurring organic acids in the plant kingdom. It is found in significant quantities in a wide range of fruits and vegetables, where it contributes to characteristic tart flavor profiles and plays metabolic roles in plant tissue.

• Citrus fruits: Lemons and limes contain the highest concentrations, typically 4–8% citric acid by fresh weight (approximately 40–80 g/L of juice). Grapefruits and oranges contain lower but still substantial amounts (1–3%).
• Berries: Strawberries, raspberries, gooseberries, and blackcurrants are notable sources, with concentrations typically in the range of 1–2% by fresh weight.
• Stone fruits: Peaches, apricots, plums, and cherries contain moderate amounts.
• Tomatoes: Contain citric acid as a major organic acid alongside malic acid.
• Pineapple: Contains citric acid alongside malic acid; the balance between the two influences flavor.
• Vegetables: Present in lower concentrations in broccoli, peppers, potatoes, and leafy greens.

Citric acid is also produced endogenously in the human body as an obligate intermediate of the Krebs (tricarboxylic acid) cycle in virtually every aerobic cell. It is present in human blood at low micromolar concentrations and is excreted in urine, where it plays a role in preventing kidney stone formation.